AAM
BIIB icon

Azzad Asset Management’s Biogen BIIB Stock Holding History

Azzad Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$601K Buy
+2,784
New +$533K 0.05% 289
2022
Q4 		– Sell
-5,438
Closed -$1.45M – 320
2022
Q3 		$1.45M Sell
5,438
-9
-0.2% -$1.91K 0.15% 207
2022
Q2 		$1.44M Buy
+5,447
New +$1.11M 0.14% 213
2021
Q2 		– Sell
-6,411
Closed -$1.79M – 325
2021
Q1 		$1.79M Buy
6,411
+216
+3% +$58.3K 0.3% 141
2020
Q4 		$1.52M Sell
6,195
-40
-0.6% -$10.3K 0.28% 146
2020
Q3 		$1.77M Buy
6,235
+997
+19% +$278K 0.37% 103
2020
Q2 		$1.4M Buy
5,238
+2,402
+85% +$722K 0.33% 113
2020
Q1 		$897K Sell
2,836
-5,179
-65% -$1.57M 0.26% 142
2019
Q4 		$2.23M Buy
8,015
+42
+0.5% +$11.7K 0.26% 138
2019
Q3 		$2.04M Buy
7,973
+5,258
+194% +$1.22M 0.25% 144
2019
Q2 		$635K Buy
2,715
+1,117
+70% +$258K 0.17% 203
2019
Q1 		$378K Sell
1,598
-22
-1% -$6.93K 0.11% 247
2018
Q4 		$488K Sell
1,620
-118
-7% -$37.7K 0.16% 214
2018
Q3 		$614K Sell
1,738
-17
-1% -$5.85K 0.16% 212
2018
Q2 		$509K Buy
1,755
+35
+2% +$9.84K 0.15% 231
2018
Q1 		$471K Buy
1,720
+47
+3% +$14.6K 0.14% 231
2017
Q4 		$533K Buy
1,673
+79
+5% +$25.3K 0.17% 191
2017
Q3 		$499K Buy
1,594
+94
+6% +$27.8K 0.17% 200
2017
Q2 		$407K Buy
1,500
+132
+10% +$34.9K 0.15% 221
2017
Q1 		$374K Buy
1,368
+127
+10% +$35.9K 0.14% 217
2016
Q4 		$352K Buy
1,241
+44
+4% +$13K 0.15% 209
2016
Q3 		$375K Sell
1,197
-19
-2% -$5.63K 0.15% 207
2016
Q2 		$294K Buy
1,216
+420
+53% +$111K 0.13% 222
2016
Q1 		$207K Buy
796
+116
+17% +$30.6K 0.09% 230
2015
Q4 		$208K Buy
+680
New +$195K 0.1% 229

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Azzad Asset Management's BIIB Position: Q2 2026 in Review

Azzad Asset Management opened a new position in Biogen (BIIB) in Q2 2026: 2,784 shares worth $601K. The stake represents 0.05% of the portfolio and ranks #289 among its holdings. This is a return to the name: Azzad Asset Management previously reported a position in BIIB as recently as Q3 2022.

Azzad Asset Management first reported a position in BIIB in Q4 2015 and has held it in 25 quarters since. The position peaked at $2.23M in Q4 2019. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Azzad Asset Management held 2,784 shares of Biogen worth $601K as of Q2 2026.
  • Biogen was a new Azzad Asset Management position in Q2 2026.
  • Biogen made up 0.05% of Azzad Asset Management's portfolio in Q2 2026, its #289 holding.
  • Azzad Asset Management first reported a position in Biogen in Q4 2015 and has held it in 25 quarters since.
  • Azzad Asset Management's Biogen position peaked at $2.23M in Q4 2019.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.